Pain Therapeutics (PTIE)

Company Overview
Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States. Its Phase III clinical trial products include Remoxy, which is an anti-abuse version of long-acting oxycodone; and Oxytrex, which is an opioid painkiller for the treatment of chronic pain. The company has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers. Pain Therapeutics was founded in 1998 and is based in South San Francisco, California.
read more

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 7801 N Capital of Texas Highway, Suite 260, Austin, TX 78731, United States
Mailing Address: -
Phone: 512-501-2444
Fax: 512-614-0414
Website: http//www.paintrials.com

Company Details:

Symbol: PTIE
SIC: 2834
State location: CA
Sector: -
State of Inc: DE
Employees: 27
Type: -

Key executives:

Name Age Position
Grant L. Schoenhard Ph.D. 71 Chief Scientific Officer
Nadav Friedmann M.D. 73 Chief Operating Officer, Chief Medical Officer
Peter S. Roddy 56 Chief Financial Officer, Principal Accounting Officer and VP
Remi Barbier 56 Founder, Chairman, Chief Exec. Officer and Pres